Sun Il Choi, Ph.D. She was appointed as the Professor of Pharmacy school at Henan University in China. Choi worked at National Cancer Center Korea for 8 years (Oct. 2012. ~ Dec. 2020.) and graduated from Ewha Womans University, Korea in Feb. 2019. The main research areas are 1) development of nucleic acid (aptamer) therapy, 2) patient-derived preclinical models. Choi is the author of <Science Advances (2019)>, <Frontiers Oncology (2019)>, <Cancer Letters (2018)>. And she has six patents about <Novel DNA aptamer and its uses> and one technical transfer to JP BIO-A Inc.
